Administration & Agency Updates

Recent Administration & Agency Updates

  • February 2, 2022·

FDA Approves Second COVID-19 Vaccine

There was another very important update around a COVID-19 vaccine that will impact all Tribal Nations. Yesterday, the U.S. Food and Drug Administration (FDA) granted full approval to a second COVID-19 vaccine. The Moderna COVID-19 vaccine, now being marketed as Spikevax, has been approved for people ages 18 and over. The Moderna vaccine (Spikevax) has been available under emergency use authorization (EUA) for people…
Learn More
  • January 25, 2022·

IHS Acting Deputy Director Urges Indian Country to Order Free At-Home COVID-19 Tests

The Indian Health Service (IHS) Acting Deputy Director, Elizabeth Fowler sent a message urging Indian Country to order their one set of four FREE at-home COVID-19 testing kits at: //www.covidtests.gov/ from the US Postal Service (USPS) is now delivering   To order, you only need to provide your name and residential mailing address. No ID, credit card, or health insurance information is required. Orders will…
Learn More
nihb_blog_default
  • January 25, 2022·

Two Billion Dollars More in Provider Relief Fund Payments to Health Care Providers Impacted by the COVID-19 Pandemic

On January 25, 2022, the U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), released two billion dollars more in Provider Relief Fund (PRF) payments to healthcare providers impacted by the COVID-19 pandemic. More than 7,600 providers across the country received the payments in the last week of January as part of the Phase 4 General Distribution.…
Learn More
  • January 18, 2022·

USPS to Deliver Free at-Home test COVID-19 Kits

The US Postal Service (USPS) is now delivering FREE at-home rapid tests! Residential households in the U.S. can now order one set of four free at-home COVID-19 testing kits. There is a limit of one order per household. Each order includes four individual rapid COVID-19 tests, and will ship for free starting in late January.   To order your at-home testing kit:   Step…
Learn More
  • January 10, 2022·

CDC Releases Updated Healthcare Worker Isolation and Quarantine Guidance

With the increased number of COVID-19 cases from the Omicron variant, the Centers for Disease Control and Prevention (CDC) released updated guidance for isolation and quarantine for healthcare workers. The guidance decreases the amount of isolation time after infection with COVID-19. The CDC also released an update to guidance for contingency and crisis management in settings with significant healthcare worker shortages. The updated guidance…
Learn More
  • January 4, 2022·

CDC Recommends Pfizer Booster at 5 Months, Additional Primary Dose for Certain Immunocompromised Native Youth

On January 4, 2022, Dr. Rochelle Walensky, Director of the Centers for Disease Control and Prevention (CDC), issued two COVID-19 related recommendations following actions by the Food and Drug Administration (FDA). First, American Indians and Alaska Natives who received the Pfizer Bio-NTech COVID-19 vaccine as their primary series are now recommended to get their booster after 5 months, instead of 6 months. Second, moderately,…
Learn More

Contact Us

To reach the NIHB COVID-19 Response Team, please contact [email protected].

For media inquiries, please contact Ned Johnson at [email protected].

Facebook Twitter Instagram Youtube

© Copyright 2020, National Indian Health Board. All Rights Reserved. Website by DrawBridge Creative.

Privacy Policy

This website is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of financial assistance awards totaling $2,000,000, Tribal Capacity Building for COVID-19 Disease Control, and $4,000,000, Addressing COVID-19 Vaccine Confidence Through Tribal Health Departments, with 80 percent funded by CDC/HHS, and 20 percent funded by non-government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.